Life sciences partner Greg Levine (Washington, D.C.) was quoted in FDA Week and Inside Health Policy on Aug. 12 regarding U.S. Food and Drug Administration (FDA) draft guidance stating that medical device manufacturers can make software modifications to improve cybersecurity or restore a device to recently cleared specifications without having to submit new 510(k) documentation.
Mr. Levine explains that while the new FDA guidelines are clearer than previously existing medical device software modification guidance, it is still vague and open to interpretation.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.